Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registryMarwa Amer, Ahmed Kamel, Mohammed Bawazeer et al.|European journal of medical research|2021Cited by 26
Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrestWilliam J. Meurer, Robert Silbergleit, Kristine Broglio et al.|Trials|2024Cited by 15
Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registryChristian Kirkup, Venky Soundararajan, Colin Pawlowski et al.|Journal of Medical Virology|2021Cited by 10
Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrestWilliam J. Meurer, Robert Silbergleit, Florian Schmitzberger et al.|Research Square|2024Cited by 4
Clinical Characteristics and Outcomes of Critically ill Mechanically Ventilated COVID-19 Patients Receiving interleukin-6 Receptor Antagonists and Corticosteroid Therapy: A Multicenter International Observational StudyMarwa Amer, Rahul Kashyap, Mohammed Bawazeer et al.|medRxiv|2021Cited by 3